Comprehensive molecular profiling to predict clinical outcomes in pancreatic cancer.

Jung Yong HongHee Jin ChoSeung Tae KimYoung Suk ParkSang Hyun ShinIn Woong HanJeeyun LeeJin Seok HeoJoon Oh Park

Published in: Therapeutic advances in medical oncology (2021)

We identified potential prognostic biomarkers and therapeutic targets of patients with PDAC. Understanding these molecular aberrations that determine patient outcomes after surgery and chemotherapy has the potential to improve the treatment outcomes of PDAC patients.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
gene expression
single cell
single molecule
squamous cell carcinoma
radiation therapy
locally advanced
copy number
climate change
rectal cancer
patient reported